A detailed history of Eclectic Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Eclectic Associates Inc holds 1,047 shares of ABBV stock, worth $187,622. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,047
Holding current value
$187,622
% of portfolio
0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$163.84 - $199.33 $171,540 - $208,698
1,047 New
1,047 $206,000
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $247,066 - $306,540
-1,872 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $201,108 - $254,460
1,872 New
1,872 $253,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Eclectic Associates Inc Portfolio

Follow Eclectic Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eclectic Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Eclectic Associates Inc with notifications on news.